Navigation Links
Reprogramming patients' cells offers powerful new tool for studying, treating blood diseases
Date:7/30/2013

First produced only in the past decade, human induced pluripotent stem cells (iPSCs) are capable of developing into many or even all human cell types. In new research, scientists reprogrammed skin cells from patients with rare blood disorders into iPSCs, highlighting the great promise of these cells in advancing understanding of those challenging diseasesand eventually in treating them.

"The technology for generating these cells has been moving very quickly," said hematologist Mitchell J. Weiss, M.D., Ph.D., corresponding author of two recent studies led by The Children's Hospital of Philadelphia (CHOP). "These investigations can allow us to better understand at a molecular level how blood cells go wrong in individual patientsand to test and generate innovative treatments for the patients' diseases."

Weiss, with Monica Bessler, M.D., Philip Mason, Ph.D., and Deborah L. French, Ph.D., all of CHOP, led a study on iPSCs and Diamond Blackfan anemia (DBA) published online June 6 in Blood. Another study by Weiss, French and colleagues in the same journal on April 25 focused on iPSCs in juvenile myelomonocytic leukemia (JMML).

In DBA, a mutation prevents a patient's bone marrow from producing normal quantities of red blood cells, resulting in severe, sometimes life-threatening anemia. This basic fact makes it difficult for researchers to discern the underlying mechanism of the disease: "It's very difficult to figure out what's wrong, because the bone marrow is nearly empty of these cells," said Bessler, the director of CHOP's Pediatric and Adult Comprehensive Bone Marrow Failure Center.

The study team removed fibroblasts (skin cells) from DBA patients, and in cell cultures, using proteins called transcription factors, reprogrammed the cells into iPSCs. As those iPSCs were stimulated to form blood tissues, like the patient's original mutated cells, they were deficient in producing red blood cells.

However, when the r
'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Reprogramming cells to fight diabetes
2. A relationship between cancer genes and the reprogramming gene SOX2 discovered
3. Doctors urged to talk to patients about parking cellphones
4. Inhalable gene therapy may help pulmonary arterial hypertension patients
5. Requiring some patients to get mental health treatment saves money
6. Looking at outcomes important to patients may improve results of cataract surgery
7. Diet Doc Medical Weight Loss Plans Now Encourages Natural Weight Loss With Fruits and Vegetables that Help Patients Lose Weight Fast and Live Longer
8. Itani Dental Explains How to Choose a Dentist for Special Needs Patients
9. Active Family Chiropractic of Gaithersburg, MD Introduces Nutra Disc, a New Dietary Supplement Designed to Support Patients’ Spinal Disc and Connective Tissue Health
10. Diet Doc Medical Weight Loss Plans Now Help Patients Eliminate Junk Food From Their Weight Loss Diets with Fat Burning Snack Ideas
11. PositiveSingles.com and The Henne Group Partner to Conduct a Study on HIV Patients in LA and DC in Hopes to Support the Creation of a Campaign in the Fight Against HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
(Date:5/22/2015)... “It’s like learning an new ... Vice President of Clinical Operations/Education and Training at ... impacts how care is coded and reimbursed.” , ... care reimbursement, operations and compliance consulting, as well ... launches a new series of day-long seminars on ...
(Date:5/22/2015)... Carnegie Science Center and ... partnership to develop BodyTech, a dynamic, three-pronged health and ... a new exhibit at the Science Center called BodyWorks, ... new traveling science show, Anatomy Adventure, which will hit ... Designed to explore a wide range of topics surrounding ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning ... some tips to help promote safe travel. , According to ... traffic fatalities this Memorial Day weekend. Amica is sharing the ... Association: , , Always wear a ... seatbelt, whether they’re driving or riding along as a passenger. ...
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of ... is in his second year of racing in the professional ... Fire Department in Missoula, MT. He entered the triathlon scene ... career, he has had 15 1st Place finishes. In his ... in all seven of his 2014 races, including two 2nd ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... Poor sleep tied to quality of life, depression, study says ... common among elderly people who live in assisted living facilities, ... associated with declining quality of life and increased depression. , ... when they,re no longer able to live independently but do ...
... while longer-term risks are uncertain , FRIDAY, May 7 ... Gulf of Mexico and now some barrier islands off ... environment while posing risks to public health, experts say. ... headaches, nausea, coughing and throat irritation, according to the ...
... from a corticosteroid regimen have fewer cardiovascular events ... survival rates and reducing early mortality, according to ... of Cincinnati (UC) transplantation researchers. Researchers with ... medicine are presenting the work at the American ...
... explain different outcomes for women with similar-looking tumors, expert ... of breast cancer into subtypes can be achieved through ... U.S. researchers say. , They analyzed 32 gene expression ... and six classification models. , "We studied these models ...
... breast cancer , C.B. Agborsangaya, FINLAND, As women ... the incidence of pregnancy-associated breast cancer is expected ... p53 autoantibody-positive pregnant women may be useful in ... cancer. Abstract 92P: Post traumatic stress disorder ...
... a benign tumor of mesenchymal origin which is mostly ... 2/3 of small bowel occlusion caused by up to ... frequent benign tumor that causes invagination in its submucous ... form. However, multiple lipomas within the intestinal duplication canal ...
Cached Medicine News:Health News:Sleepless Nights Plague Assisted Living Residents 2Health News:Gulf Oil Spill Could Threaten Human Health 2Health News:Gulf Oil Spill Could Threaten Human Health 3Health News:Study finds post-transplant patients off steroids have fewer cardiovascular events 2Health News:Study finds post-transplant patients off steroids have fewer cardiovascular events 3Health News:Simple Test May Identify Breast Cancer Subtypes 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 3
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
(Date:5/22/2015)... KING OF PRUSSIA, Pa. , May 22, 2015 ... CSL Behring its 2015 Corporate Leadership Award as ... science and improving the care of the bleeding disorders community.  ... and Managing Director, CSL Limited, during the NHF Annual Spring ... May 21. "The National Hemophilia Foundation is dedicated ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4
... July 29 Micromet, Inc.,(Nasdaq: MITI ), ... treatment of cancer, inflammation and autoimmune,diseases, today announced ... audio,webcast on Thursday, August 7, 2008, at 9:00 ... discuss its second quarter 2008 financial,results. Micromet anticipates ...
... July 28 BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ... study of intravenous (i.v.) peramivir administered via a ... treatment of seasonal,influenza. The trial, conducted by BioCryst,s ... primary endpoint of improvement in the median time ...
Cached Medicine Technology:Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 4BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 5
... its synthetic bone substitute Ossatura. Developed at Isotis, ... material, i.e. a material that is designed to ... the musculo-skeletal system that results in bone growth. ... and reduces in part or entirely the need ...
Schuknecht-Weitlaner retractor, sharp, angled arms....
Beckman-Weitlaner retractor, blunt, with hinged arms, 6 1/2"....
Daubenspeck sharp curette, 8....
Medicine Products: